Investing Profile

Stacey Seltzer

VC
Photo of Stacey Seltzer, Partner at Aisling Capital
cb
3
$280M
CompanyStageDateRound SizeTotal Raised
Aimmune Therapeutics
Series BMar 2015$80M
$80M
Co-investors: Jim Tananbaum (Foresite Capital)
Agile Therapeutics
Post Ipo EquityFeb 2015$20M
Series CJul 2012$40M
$110M
Co-investors: Karen Hong (Novo Ventures), Andrew Schiff (Aisling Capital)